Organization

Penn State Milton S. Hershey Medical Center, Hershey, PA

24 abstracts

Abstract
The role of the ubiquitin ligase UBE4B in neural tumors in adults and children.
Org: UCSD, San Diego, CA, Caris Life Sciences, Irving, TX, Caris Life Sciences, Phoenix, AZ, West Virginia University, Morgantown, WV, University of Minnesota Masonic Cancer Center, Minneapolis, MN,
Abstract
Metabolic profile and therapeutic vulnerabilities of multi-omic characterization of KRAS/STK11/KEAP1 co-mutant non–small cell lung cancer (NSCLC).
Org: Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA, Caris Life Sciences Research and Development, Montefiore Einstein Comprehensive Cancer Center/Albert Einstein College of Medicine,
Abstract
Immunotherapy outcomes and profile in lung cancer brain metastases.
Org: Caris Life Sciences, Irving, TX, Levine Cancer Institute, West Virginia University Camden Clark Medical Center, Penn State Milton S. Hershey Medical Center, Hershey, PA, Rhode Island Hospital,
Abstract
Evaluation of the genomic and immune profiles of patients with lung adenosquamous carcinoma (LUAS) and association of response to treatment.
Org: Caris Life Sciences, Irving, TX, The Warren Alpert Medical School of Brown University, Columbia University Irving Medical Center, New York, NY, USA, Yale Cancer Center, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Hematology/oncology fellowship programs’ instagram presence.
Org: Penn State Health Milton S. Hershey Medical Center, Penn Medicine Abramson Cancer Center, Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA, Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan,
Abstract
CSF proteomics for predicting response to treatment in patients with primary and secondary central nervous system lymphoma.
Org: Penn State College of Medicine, University Park, PA, PainReform, University of Toronto, Toronto Allergy and Asthma Centre,
Abstract
Survival and mutational differences based on ESR1 and ESR2 expression in non-small cell lung cancer (NSCLC).
Org: Norris Comprehensive Cancer Center, University of Southern California Marshall School of Business, Caris Life Sciences, Irving, TX, University of California, Irvine Medical Center, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
Association of CDK4 amplification with duration of response to bevacizumab in glioblastoma.
Org: Caris Life Sciences, Irving, TX, Saint John's Cancer Institute at Providence Saint John's Health Center, West Virginia University Camden Clark Medical Center, Rhode Island Hospital, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Distinct molecular features and potential therapeutic strategies for spinal cord gliomas.
Org: Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA, Levine Cancer Institute, West Virginia University Camden Clark Medical Center, Duke University Medical Center,
Abstract
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas.
Org: Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA, Duke University Department of Anesthesiology, Northwestern Medicine Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University,
Abstract
Multi-cancer brain metastasis risk score development and validation using 220,246 whole transcriptomes and machine learning.
Org: Caris Life Sciences, Irving, TX, Duke Cancer Institute, Magee-Womens Hospital of UPMC/ UPMC Hillman Cancer Center, Penn State Milton S. Hershey Medical Center, Hershey, PA, Massachusetts General Hospital,
Abstract
The genomic, transcriptomic, and immunologic landscape in solid tumors expressing leukocyte immunoglobulin-like receptor B2 (LILRB2).
Org: Caris Life Sciences, Irving, TX, Montefiore Einstein Center for Cancer Care, Penn State Milton S. Hershey Medical Center, Hershey, PA, Brown University - Lifespan Cancer Institute, West Cancer Center and Research Institute,
Abstract
Large-scale transcriptomic profiling of the tumor immune microenvironment in ALK+ lung cancer.
Org: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, The Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD, Johns Hopkins Kimmel Cancer Center,
Abstract
Updated molecular analysis of MET exon 14 skipping mutations (METex14) in non-small cell lung cancer (NSCLC).
Org: Caris Life Sciences Research and Development, Emory University School of Medicine, University Of California San Diego Ideka Laboratory, Caris Life Sciences, Irving, TX, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
The genomic, transcriptomic, and immunological landscape of TROP2 in solid tumors.
Org: Caris Life Sciences, Irving, TX, Lombardi Comprehensive Cancer Center, Montefiore Einstein Center for Cancer Care, St. John's Cancer Institute, Santa Monica, CA, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Survival associations and driver oncogene overlap for copy-number amplifications of ERBB2, KRAS and MET in non-small cell lung cancer.
Org: Tom Baker Cancer Center, Calgary, AB, Canada, Caris Life Sciences, Irving, TX, Irving, TX, Phoenix, AZ,
Abstract
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
Org: University of Miami/Jackson Memorial Hospital, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Caris Life Sciences, Irving, TX, Jackson Memorial Hospital/ University of Miami, Lombardi Comprehensive Cancer Center, Georgetown University,
Abstract
Spectrum of acquired KRAS mutations in driver mutation-positive non-small cell lung cancer.
Org: Caris Life Sciences, Irving, TX, West Virginia University Health Sciences Center Department of Epidemiology and Biostatistics, Mayo Clinic, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Characterizing non-small cell lung cancer driven by mutations in ARAF and CRAF family members.
Org: Ohio State University Comprehensive Canvcer Hospital, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea, Department of Internal Medicine C, University Hospital Greifswald, Greifswald, Germany, James Thoracic Center, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH,
Abstract
Implementing liquid biopsy in rural cancer care when tissue is insufficient for molecular testing: Retrospective review.
Org: Sarah Cannon Cancer Institute at Research Medical Center, UMKC Medical school, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Org: Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, PA,
Abstract
Molecular characterization of nectin-4 in non-small cell lung cancer subtypes.
Org: Caris Life Sciences Research and Development, Lombardi Comprehensive Cancer Center, Barbara Ann Karmanos Cancer Institute, Montefiore Einstein Center for Cancer Care, Caris Life Sciences, Irving, TX,
Abstract
D-CRSE: Diminishing chemotherapy related side effects through patient education.
Org: Penn State Hershey Medical Center, Penn State Milton S. Hershey Medical Center, Hershey, PA, Penn State College of Medicine, Penn State Cancer Institute - Milton S Hershey Medical Center, Penn State Cancer Institute,
Abstract
Impact of CLEC3B mRNA expression on genetic landscape and immune tumor-microenvironment in NSCLC.
Org: Caris Life Sciences, Irving, TX, Huntsman Cancer Institute, UPMC Hillman Cancer Center, Barbara Ann Karmanos Cancer Institute, University of Minnesota Masonic Cancer Center, Minneapolis, MN,